国发股份 (600538)

Beihai Gofar Chuanshan Biological Co., Ltd.

ASH

Tags

Long-Term Non-Dividend PayersLow Safety ScorePharmaceuticals and HealthcarePharmaceutical CommerceGene ConceptMicro and Small Cap StocksWholesaleDispersed Shareholding医药生物

K-Line Chart

No K-line data available

Company NameBeihai Guofa Chuanshan Biotechnology Co., Ltd.
Listing Date2003-01-14
Issue Price6.69RMB
Registered Capital52419.834810k RMB
Legal RepresentativeJiang Ye
Registered AddressNo. 3 Middle Beibu Gulf Road, Beihai City, Guangxi Province
IndustryPharmaceutical Business
Main BusinessResearch, development, production, and sales of marine biological series products such as algae, shellfish, and crustaceans.
Company ProfileBeihai Guofa Chuanshan Biotechnology Co., Ltd., formerly known as Beihai International Economic Development Co., Ltd., is a listed company engaged in the comprehensive development and processing of marine biological resources. It was jointly initiated by enterprises from ethnic regions such as Guangxi, Tibet, and Inner Mongolia, with equity participation and cooperation from institutions including Tsinghua University, the Institute of Oceanology of the Chinese Academy of Sciences, and the Agricultural Planning and Design Institute of the Ministry of Agriculture.

Stock Details

1. Key Indicators

  • Total Shares(W): 52419.83
  • Circulating A-Shares(W): 52419.83
  • Earnings Per Share(RMB): -0.0070
  • Net Assets Per Share(RMB): 1.4719
  • Operating Revenue(W RMB): 23907.16
  • Total Profit(W RMB): -50.93
  • **Net Profit Attributable to Parent(W RMB) **: -385.13
  • Net Profit Growth Rate(%): 81.56
  • Weighted Return on Equity(%): -0.5000
  • Operating Cash Flow Per Share(RMB): -0.0570
  • Undistributed Profit Per Share(RMB): -1.0882
  • Capital Reserve Per Share(RMB): 1.4973

2. Main Business

The main business covers:

  • Pharmaceutical manufacturing and pharmaceutical distribution industry
  • Molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technology services
  • Hotel services, etc.

3. Company Basic Information

  • Company Name: Beihai Guofa Chuanshan Biotechnology Co., Ltd.
  • Listing Date: 2003-01-14
  • Industry: Medicine and Healthcare - Pharmaceutical Commerce (Tongdaxin Research Industry)
  • Address: No. 3 North Bay Middle Road, Beihai City, Guangxi Zhuang Autonomous Region
  • Website: http://www.gofar.com.cn
  • Company Profile: The company was formerly known as Beihai International Economic Development Co., Ltd. It was established on January 22, 1993, through a directional private placement approved by document Gui Tigaigu Zi [1992] No. 50 from the Guangxi Zhuang Autonomous Region Economic System Reform Commission. The founding shareholders were Beihai Jinghai Industrial Development Co., Ltd. (formerly Beihai Yongyu Real Estate Development Company), Beijing Baiyun Malaqin Hotel (formerly Beijing Inner Mongolia Malaqin Hotel), and Guangxi Beihai Maritime Transport General Company, who contributed cash. At establishment, the total share capital was 6,580,000 shares, consisting of 3,619,000 promoter legal person shares, 1,645,000 privately placed corporate legal person shares, and 1,316,000 internal employee shares. On December 13, 1998, approved by document Gui Tigaigu Zi [1998] No. 31 from the Guangxi Zhuang Autonomous Region Economic System Reform Commission,

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Wenzhou Qiyuan Asset Management Co., Ltd. - Qiyuan Zunxiang No. 2 Private Securities Investment Fund Private Securities Investment Fund 1000.00 1.91
2 Guangzhou Yuanshi Investment Management Co., Ltd. - Yuanshi Honglong No. 1 Private Securities Investment Fund Private Securities Investment Fund 655.16 1.25
3 Shengshi Rongbang (Guangzhou) Private Securities Investment Fund Management Co., Ltd. - Shengshi Rongbang No. 9 Securities Private Investment Fund Private Securities Investment Fund 625.39 1.19
4 Guangdong Qianbei Private Fund Management Co., Ltd. - Qianbei Heying No. 1 Private Securities Investment Fund Private Securities Investment Fund 481.36 0.92

5. Concept Sectors

  • Gene Concept
  • Consecutive Losses
  • Dispersed Ownership
  • Long-Term No Dividends
  • Low Safety Score
  • Micro and Small Cap Stock

Remarks

  • Data update date: 2025-10-30
  • Data source: Public Market Information